4
Changes in Ownership
Grace Therapeutics, Inc. Filed Acc 0001140361-25-014263
Options or other derivatives
- Chief Executive Officer acquired 225,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kohli Prashant Chief Executive Officer | 2025-04-14 | Grant or award · Stock Option (Right to Buy) | +225,400 | 225,400 | D | ||
Loading xslF345X05/form4.xml…